A Mendelian randomisation study provides initial evidence that sex hormone binding globulin (SHBG) levels alter type 2 diabetes risk
Main Authors: | Perry, J, Melzer, D, Maggio, M, Hernandez, D, Singleton, A, Ferrucci, L, Palmer, C, Bennett, A, Ruokonen, A, Panicker, V, Jarvelin, M, Hattersley, A, Mccarthy, M, Frayling, T |
---|---|
Format: | Conference item |
Published: |
2008
|
Similar Items
-
Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes.
by: Perry, JR, et al.
Published: (2010) -
Sex Hormone Binding Globulin (SHBG) Mitigates ER Stress in Hepatocytes In Vitro and Ex Vivo
by: Katarzyna Kornicka-Garbowska, et al.
Published: (2021-03-01) -
Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
by: Xianqin Qu, et al.
Published: (2020-11-01) -
Sex hormone binding globulin (SHBG) as a predictor of liver fibrosis in subjects with nonalcoholic fatty liver disease (NAFLD)
by: Abeer Abdel-latif, et al.
Published: (2023-05-01) -
Associations of bone mineral density with sex hormone-binding globulin (SHBG) and testosterone in middle-aged Saudi men: a cross-sectional study
by: Sobhy M. Yakout, et al.
Published: (2023-11-01)